Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
During Pregnancy
100%
Inflammatory Bowel Disease
100%
Prospective multicenter Cohort Study
100%
Ustekinumab
100%
Tumor Necrosis Factor-α
50%
Neonatal Outcomes
21%
Pregnancy Outcome
14%
Pregnant Women
14%
Hospitalization
7%
No Significant Difference
7%
Crohn's Disease
7%
Remission
7%
Body Mass Index
7%
First Year
7%
Maternal Outcomes
7%
Low Birth Weight
7%
Preterm Delivery
7%
Anti-tumor Necrosis Factor Agents
7%
Thiopurines
7%
Overall Outcome
7%
Maternal Complications
7%
Anti-tumor Necrosis Factor Therapy
7%
Mesalazine
7%
Newborn Outcomes
7%
Multicenter Prospective Cohort Study
7%
Medicine and Dentistry
Cohort Analysis
100%
Patient with Inflammatory Bowel Disease
100%
Ustekinumab
100%
Tumor Necrosis
50%
Neonatal Infant
21%
Inflammatory Bowel Disease
14%
Body Mass Index
7%
Tumor Necrosis Factor
7%
Biological Product
7%
Calcium Ion
7%
Prospective Cohort Study
7%
Premature Labor
7%
Low Birth Weight
7%
Crohn's Disease
7%
TNF Inhibitor
7%
Mercaptopurine
7%
Mesalazine
7%
Preterm Delivery
7%